Internal Medicine, Pulmonary Disease · Greensboro, NC
NPI
1558310276
Since 2006
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
520 N Elam Ave
Greensboro, NC, 27403
Phone (336) 547-1801
Groups this clinician bills Medicare through
Medicare paid, 2024
$43K
3,297 services
Medicare patients, 2024
251
Average age 75
Drug cost, 2024
$1.5M
6,931 prescriptions
Company payments, 2025
$53K
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Michael B Wert was code J1010 (injection, methylprednisolone acetate, 1 mg), 2,680 times for 18 patients. In total Michael B Wert billed 3,297 services in 28 codes, and Medicare paid $43K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-12-05.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 2,680 | 18 | $0.09 | $252 |
| 99214 Office E&M - Established | Office | 180 | 121 | $86.42 | $16K |
| 99213 Office E&M - Established | Office | 104 | 87 | $58.16 | $6,049 |
| 99204 Office E&M - New | Office | 54 | 54 | $117.62 | $6,352 |
| 99215 Office E&M - Established | Office | 43 | 40 | $127.32 | $5,475 |
| 99406 Behavioral Health Services | Office | 32 | 27 | $13.26 | $424 |
| 71046 X-ray - Chest | Office | 31 | 29 | $15.16 | $470 |
| 96372 Injection Administration | Office | 30 | 24 | $9.56 | $287 |
| 99205 Office E&M - New | Office | 27 | 27 | $158.30 | $4,274 |
| 94664 E&M - Miscellaneous | Office | 16 | 16 | $12.11 | $194 |
| 99203 Office E&M - New | Office | 13 | 13 | $58.15 | $756 |
| 95012 Pulmonary | Office | 12 | 11 | $11.42 | $137 |
By year: 2022 $65K for 1,300 services; 2023 $52K for 799 services; 2024 $43K for 3,297 services.
Lab tests billed to Medicare, 2023
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 23 | 23 | $7.61 | $175 |
| 80048 Clinical Chemistry | 12 | 12 | $8.29 | $99.48 |
| 83880 Clinical Chemistry | 11 | 11 | $38.47 | $423 |
Medicare prescription drug claims, 2024
In 2024, the drug Michael B Wert prescribed most often to Medicare patients was Famotidine, with 1,070 prescriptions and refills. In total Michael B Wert wrote 6,931 Medicare prescriptions that cost $1.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Famotidine Generic | 1,070 | 1,890 | 321 | $8,727 |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 670 | 759 | 136 | $477K |
| Pantoprazole Sodium Generic | 638 | 1,189 | 228 | $4,927 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 587 | 656 | 150 | $15K |
| Prednisone Generic | 550 | 678 | 244 | $2,021 |
| Symbicort Budesonide/Formoterol Fumarate | 468 | 605 | 126 | $131K |
| Stiolto Respimat Tiotropium Br/Olodaterol Hcl | 308 | 369 | 58 | $177K |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 282 | 342 | 61 | $219K |
| Budesonide-Formoterol Fumarate Budesonide/Formoterol Fumarate | 196 | 217 | 57 | $33K |
| Montelukast Sodium Generic | 176 | 384 | 52 | $1,746 |
| Valsartan Generic | 175 | 306 | 57 | $2,713 |
| Dulera Mometasone/Formoterol | 141 | 173 | 34 | $57K |
| Gabapentin Generic | 134 | 179 | 43 | $1,811 |
| Olmesartan Medoxomil Generic | 134 | 224 | 34 | $1,288 |
| Azithromycin Generic | 131 | 131 | 80 | $398 |
Brand drugs: 2,902 claims; generic drugs: 4,029 claims; opioid claims: 23.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Michael B Wert $53K ($53K in general payments such as food, travel and fees) from 14 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $50K.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 80 | $50K |
| Viatris Specialty LLC | 13 | $2,009 |
| GlaxoSmithKline, LLC. GSK | 22 | $355 |
| Verona Pharma, Inc. VRNA | 17 | $238 |
| Insmed, Inc. INSM | 4 | $115 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 5 | $92.04 |
| United Therapeutics Corporation UTHR | 4 | $90.06 |
| Regeneron Healthcare Solutions, Inc. REGN | 3 | $81.33 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $66.92 |
| Merck Sharp & Dohme LLC MRK | 2 | $66.58 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.